Marilena Vrana: Advancing Early Diagnosis and Access to Plasma Medicines for World PI Week 2026
Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, shared a post on LinkedIn:
“World PI Week 2026 is here.
Working in the plasma community, I am continually inspired by the strength and resilience of the people living with Primary Immunodeficiency that I have met from around the world.
This week is an important opportunity to raise awareness, amplify patient voices, and highlight the critical importance of early diagnosis and access to care. I’m proud to stand alongside patients, advocates, and partners who are driving progress every day.
Together, we must continue working toward a future where all patients have access to the support and treatments they need, including life-saving plasma–derived medicines.”
Find more posts featuring Marilena Vrana on Hemostasis Today.
-
Jun 24, 2026, 13:50Tijjani Balas: Why Early Detection of DVT Matters
-
Jun 24, 2026, 13:43Brandon Michael Henry: Interpreting Complement Activation After AAV Gene Therapy
-
Jun 24, 2026, 13:37Heba Youssef: Heparin-Induced Thrombocytopenia – The Prothrombotic Emergency You Cannot Miss
-
Jun 24, 2026, 13:32Jecko Thachil: Understanding the Clinical Spectrum of Vitamin B12
-
Jun 24, 2026, 13:32Namrata Singh: Beyond Low Platelets – Understanding What Triggers ITP
-
Jun 24, 2026, 09:29Advancing Women’s Health Through Collaboration with Jean Hailes for Women’s Health – Stroke Foundation
-
Jun 24, 2026, 09:18The Lasting Immunological Footprint of VITT – JTH
-
Jun 24, 2026, 09:09Umberto Pensato: Dedicated Funding Pathways for Stroke Research in Italy
-
Jun 24, 2026, 09:00Danny Gaskin: BBTS 2026 and the Evolving Role of Transfusion in Maternity Care